Menu
Back to Journals » Infection and Drug Resistance » Volume 10
Original Research
Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,392 | Dovepress* | 8,066+ | 1,360 | 9,426 | |
| PubMed Central* | 326 | 115 | 441 | ||
| Totals | 8,392 | 1,475 | 9,867 | ||
| *Since 31 August 2017 | |||||
View citations on PubMed Central and Google Scholar